Exlites Holdings International, Inc. (EXHI)
0.45
0.00 (0.00%)
USD |
OTCM |
Oct 15, 16:00
Exlites Holdings International Research and Development Expense (Quarterly)
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| October 31, 2023 | 0.00 |
| July 31, 2023 | 0.00 |
| April 30, 2023 | 0.00 |
| October 31, 2022 | |
| July 31, 2022 | |
| April 30, 2022 | 0.1166M |
| January 31, 2022 | |
| October 31, 2021 | 0.00 |
| Date | Value |
|---|---|
| July 31, 2021 | 0.0125M |
| April 30, 2021 | 0.0027M |
| January 31, 2021 | 0.0032M |
| October 31, 2020 | 0.0048M |
| July 31, 2020 | 0.0052M |
| April 30, 2020 | 0.0021M |
| January 31, 2020 | 0.0075M |
| January 31, 2016 | 0.275M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Xcelerate, Inc. | -- |
| Vivos Therapeutics, Inc. | -- |
| Hinge Health, Inc. | 34.06M |
| Anika Therapeutics, Inc. | 7.341M |
| Enovis Corp. | 31.69M |